CI Investments Inc’s Adaptive Biotechnologies ADPT Stock Holding History

CI Investments Inc’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7	Closed	–	–	1263
2021 Q3	$0	Buy	+7	New	+$253	﹤0.01%	1242
2020 Q3	–	Sell	-59,902	Closed	-$2.9M	–	931
2020 Q2	$2.9M	Hold	59,902	–	–	0.02%	299
2020 Q1	$1.66M	Hold	59,902	–	–	0.01%	304
2019 Q4	$1.79M	Hold	59,902	–	–	0.01%	328
2019 Q3	$1.85M	Buy	59,902 +48,902	+445%	+$2M	0.01%	337
2019 Q2	$531K	Buy	+11,000	New	+$487K	﹤0.01%	283

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CI Investments Inc's ADPT Position: Q4 2021 in Review

CI Investments Inc sold out of Adaptive Biotechnologies (ADPT) in Q4 2021, closing a stake of 7 shares.

CI Investments Inc first reported a position in ADPT in Q2 2019 and held it in 6 quarters. The position peaked at $2.9M in Q2 2020. 214 funds tracked by Wall St. Rank hold ADPT as of Q4 2021.

CI Investments Inc reported no remaining Adaptive Biotechnologies position as of Q4 2021 after selling out during the quarter.
CI Investments Inc sold 7 Adaptive Biotechnologies shares in Q4 2021.
CI Investments Inc first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 6 quarters.
CI Investments Inc's Adaptive Biotechnologies position peaked at $2.9M in Q2 2020.
214 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2021.

Based on CI Investments Inc's 13F filing for Q4 2021, filed 11 Feb 2022.